Project Grant HT94252410761
Award Date
7/15/24
Completion Date
7/14/26
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
The Project Grant award of $1,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will support research conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition also known as "lupus brain fog." The research aims to advance...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $999,972.00 to The Feinstein Institutes For Medical Research to study urine macrophages in lupus nephritis and shed light on kidney disease processes. The award period runs from July 1, 2025 to June 30, 2029. The Feinstein Institutes, a leading non-profit medical research organization, will leverage its expertise in immunology,...
The Feinstein Institutes for Medical Research received a $921,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a study from August 15, 2022 to August 14, 2025 to research microglia as potential therapeutic targets for Autism Spectrum Disorder (ASD) using a mouse model of maternal anti-Caspr2 antibody-induced ASD. The Military Medical Research and Development program supports...
The federal Project Grant award of $837,500.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research on "OXYGEN CONSERVING REFLEX: A NOVEL MULTIMECHANISTIC THERAPEUTIC INTERVENTION FOR TBI." The research will investigate an innovative approach to address traumatic brain injury (TBI) by examining a novel oxygen conserving reflex. The award will support this...
This $1,339,689 Project Grant from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at The Feinstein Institutes for Medical Research to identify and functionally characterize metastasis-driving tumor cell subpopulations in localized stage III clear cell renal cell carcinoma. The award has a performance period from August 1, 2024 to July 31, 2028. As the research arm of Northwell Health, The Feinstein...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The U.S. Department of Defense's Defense Health Agency awarded a $300,000 Project Grant to Duke University to support the research project "COMPLEMENT-ACTIVATING PROPERTIES OF ANTI-SM/RNP ANTIBODIES IN SLE". The grant, funded through the Military Medical Research and Development (CFDA 12.420) program, will be used to conduct advanced biomedical research focused on transforming healthcare for military service members and the general public. The research aims to investigate the...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The federal Project Grant award of $997,821.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on the pathogenic role of neutrophil subpopulations in lupus nephritis, to be conducted by the Trustees of Dartmouth College over a 3-year period from November 2024 to October 2027. The grant includes two sub-awards - one to The Johns Hopkins University for $1,904 and...
This $999,975.63 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a research initiative led by the Icahn School of Medicine at Mount Sinai (ISMMS) to investigate the molecular mechanisms underlying the increased vulnerability of the APOE4 gene variant to Alzheimer's disease and identify novel therapeutic targets. The award, with a performance period from April 1, 2025 to March 31, 2028, will...